OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial

    NEXT STORY
    Athenex Announces Expansion of Board of Directors
    PREV STORY
    Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    I-Mab Announces Upcoming Participation at April Conferences

    author_avatar
    NASDAQ Market News

    Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    Critical Outcome Technologies Appoints Experienced Biotech Leader as Chief Scientific Officer

    LONDON, ON and BOSTON, MA--(Marketwired - May 11, 2017) - Critical Outcome Technologies Inc. ...

    author_avatar
    NASDAQ Market News